跳至主要內容

新聞與行事曆

新聞: 截至 2026-10-10
這些標記是什麼意思

重要性是模型對已發布報導給出的 1–5 分,不是對市場的預測。

已排定事件列上的影響是公司顯著度層級(高/中由圖譜中心度與規模判定;低僅用於人工整理的次要事件),不是對波動幅度的預測。

標記為已確認的財報日期,是 Yahoo Finance 認定由公司確認的;預估表示尚未公布。未加標記的列沒有可查的出處記錄。

經濟數據發布屬於總體經濟、不歸屬任何產業,因此在任何檢視下都會保留。沒有數值的發布表示尚未公布,頁面會直說,而不是顯示為零。

涵蓋被追蹤公司的即將到來的事件;已過去的事件會歸檔,並在可得時補上結果——這些結果都經人工整理並附引用,絕不杜撰。沒有結果的歷史列會顯示「結果待定」。

閉鎖期屆滿或指數調整的列會多出一行算術——將變得可賣出的股數,或指數基金必須買進的股數,以佔流通股的比例表示——依招股說明書或指數編製方法讀出,兩個數字都在該列註明出處。它陳述的是機制,不是價格走勢。由 IPO + 180 天推算出的閉鎖期日期會一直標為預估,直到公司自己說明為止。

未來

已排定 · 今天與明天 · 行事曆更新於 2026-10-12

10月12日週一 · 今天

10月13日週二

過往

已發布 · 最新在前

8月17日週一

監管

18:21
Business Wire

LYNKUET (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer

Bayer announced that Health Canada issued a Notice of Compliance expanding the indication for LYNKUET (elinzanetant) to the treatment of moderate to severe vasomotor symptoms caused by adjuvant endocrine therapy related to breast cancer, making it the first approved treatment option in Canada for that patient population. The expansion builds on Health Canada's July 2025 authorization of LYNKUET for moderate to severe VMS associated with menopause and was supported by Bayer's OASIS-4 study. LYNKUET is a once-daily oral, non-hormonal dual neurokinin-targeted therapy antagonizing both NK-1 and NK-3 receptors.

大盤 開啟原文 ↗

人事

17:27
Spectrum News 13

United Launch Alliance names Mark Peller president and CEO

United Launch Alliance named Mark Peller president and chief executive officer, with the new role starting immediately. Peller was previously chief operating officer overseeing Atlas and Vulcan rocket operations and joined ULA at its formation in 2006. He replaces interim CEO John Elbon, who stepped in after Tory Bruno left eight months earlier to lead Blue Origin's National Security Group. ULA is a joint venture whose board chair is Robert Lightfoot, president of Lockheed Martin Space, with Boeing represented by Kay Sears, vice president and general manager of Space, Intelligence & Weapon Systems.

大盤 開啟原文 ↗

財報

12:21
GlobeNewswire

Novo Nordisk A/S - share repurchase programme

Novo Nordisk filed its weekly buyback disclosure. The overall programme is for up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026, with the current tranche of up to DKK 11,200,000,010.45 running from 6 May 2026 to 1 February 2027. In the 10-14 August 2026 window the company repurchased 1,000,000 B shares, bringing the cumulative total under the tranche to 14,125,000 B shares for DKK 4,281,660,830. Following the transactions Novo Nordisk holds 42,924,876 B shares of DKK 0.10 as treasury shares, corresponding to 1.0% of the share capital.

大盤 開啟原文 ↗

合作

12:10
Yahoo Finance

RTX's Raytheon awarded $22.9 billion seven-year Tomahawk production contract

Raytheon, an RTX business, was awarded a $22.9 billion, seven-year contract by the U.S. Department of War covering an annual production ramp to more than 1,000 Tomahawk missiles and associated support. RTX said it delivered three times more Tomahawks in the first half of 2026 than in the same period of 2025. Raytheon President Phil Jasper said "Tomahawk is the Navy's most important strike weapon, able to target hostile forces hundreds of miles away without ever risking the lives of our sailors."

大盤 開啟原文 ↗

人事

11:30
L3Harris Technologies

L3Harris removes CEO Chris Kubasik over conduct, names Sam Mehta president and CEO

L3Harris Technologies appointed Sam Mehta as President and Chief Executive Officer and a member of the Board, effective immediately, after the board identified certain conduct by Chris Kubasik that was not consistent with the values of the company as outlined in its Code of Conduct — conduct L3Harris said was unrelated to financial reporting, controls, customer relationships or operational performance. Lead Independent Director Lewis Hay III was named Independent Chairman of the Board. Mehta most recently led the Space & Mission Systems and Communications & Spectrum Dominance segments and previously held leadership positions at Collins Aerospace and Sikorsky Aircraft. L3Harris reaffirmed its 2026 consolidated revenue, organic growth, segment operating margin, GAAP earnings per share and free cash flow.

大盤 開啟原文 ↗

原始消息流

所有到達的消息 · 7 天